Oncology Nursing News®
Oncology Nursing News CE
Current Issue
September 2019
View Past Issues
OncNurse TV
Cognitive Behavior Therapy Can Combat Fatigue
Cognitive Behavior Therapy Can Combat Fatigue
Immunotherapy for Patients with Small-Cell Lung Cancer
Immunotherapy for Patients with Small-Cell Lung Cancer
Financial Toxicity Impacts Symptom Burden
Financial Toxicity Impacts Symptom Burden
View more >>

Oncology Nursing Articles

FDA Grants Priority Review to Enfortumab Vedotin for Metastatic Urothelial Cancer
FDA Grants Priority Review to Enfortumab Vedotin for Metastatic Urothelial Cancer
BY CONOR KILLMURRAY
Expert Discusses Violence Against Nurses
Expert Discusses Violence Against Nurses
BY BRIELLE BENYON
Addressing Racial Disparities in Mesothelioma Treatment in Real-Time
Addressing Racial Disparities in Mesothelioma Treatment in Real-Time
BY CONOR KILLMURRAY
Partial-Breast Radiation Promising for Some Breast Cancer Survivors
Partial-Breast Radiation Promising for Some Breast Cancer Survivors
BY BRIELLE BENYON
The HER2-Positive Metastatic Breast Cancer Landscape Could Gain a New Combination Treatment
The HER2-Positive Metastatic Breast Cancer Landscape Could Gain a New Combination Treatment
BY JASON M. BRODERICK
MET Inhibitor Tepotinib is Granted a Breakthrough Designation by the FDA
MET Inhibitor Tepotinib is Granted a Breakthrough Designation by the FDA
BY GINA COLUMBUS
New Targeted Therapies for EGFR-mutated and HER2-positive NSCLC Have Emerged
New Targeted Therapies for EGFR-mutated and HER2-positive NSCLC Have Emerged
BY CONOR KILLMURRAY
For Patients with KRAS G12C-mutated NSCLC a New Inhibitor Was Granted a Fast Track Designation
For Patients with KRAS G12C-mutated NSCLC a New Inhibitor Was Granted a Fast Track Designation
BY LISA ASTOR
Emerging Treatments for Patients with Myeloma Prove Promising Despite Obstacles
Emerging Treatments for Patients with Myeloma Prove Promising Despite Obstacles
BY CONOR KILLMURRAY
A New First-Line Treatment for Patients with METex14-Mutated NSCLC is Granted a Breakthrough Designation by the FDA
A New First-Line Treatment for Patients with METex14-Mutated NSCLC is Granted a Breakthrough Designation by the FDA
BY GINA COLUMBUS
Nurses: Are You Prepared to Handle Immune-Related Toxicities?
Nurses: Are You Prepared to Handle Immune-Related Toxicities?
BY BRIELLE BENYON
Nurses Can Address Psychosocial Needs, From Diagnosis to Survivorship
Nurses Can Address Psychosocial Needs, From Diagnosis to Survivorship
BY MIKE HENNESSY, SR, CHAIRMAN AND CEO
View more >>
Latest Contributor Articles
What's In a Name?
What's In a Name?
By Debi Boyle MSN, RN, AOCNS, FAAN
View more >>
Strategic Alliance Partnership
We've partnered with leading institutions to bring you the most recent findings in the field of oncology. Click below for offerings from our partners
 
Latest Advocacy News
Nurses Can Refer Patients to Reliable Stomach Cancer Information
Nurses Can Refer Patients to Reliable Stomach Cancer Information
By Brittnay Starks, Communications Coordinator & Britt Ehren, MS, MFT, Programs Director
View more >>
External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.